CANbridge Pharmaceuticals Inc. (1228.HK)

HKD 0.14

(-8.05%)

Total Assets Summary of CANbridge Pharmaceuticals Inc.

  • CANbridge Pharmaceuticals Inc.'s latest annual total assets in 2023 was 395.36 Million CNY , down -43.68% from previous year.
  • CANbridge Pharmaceuticals Inc.'s latest quarterly total assets in 2024 Q1 was 248.94 Million CNY , down -37.03% from previous quarter.
  • CANbridge Pharmaceuticals Inc. reported annual total assets of 702.04 Million CNY in 2022, down -21.34% from previous year.
  • CANbridge Pharmaceuticals Inc. reported annual total assets of 892.52 Million CNY in 2021, up 52.21% from previous year.
  • CANbridge Pharmaceuticals Inc. reported quarterly total assets of 248.94 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • CANbridge Pharmaceuticals Inc. reported quarterly total assets of 569.04 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of CANbridge Pharmaceuticals Inc. (2023 - 2019)

Historical Annual Total Assets of CANbridge Pharmaceuticals Inc. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 395.36 Million CNY -43.68%
2022 702.04 Million CNY -21.34%
2021 892.52 Million CNY 52.21%
2020 586.35 Million CNY 562.18%
2019 88.55 Million CNY 0.0%

Peer Total Assets Comparison of CANbridge Pharmaceuticals Inc.

Name Total Assets Total Assets Difference
Uni-Bio Science Group Limited 409.99 Million HKD 3.568%
CK Life Sciences Int'l., (Holdings) Inc. 11.24 Billion HKD 96.485%